Featured
Remdesivir
The broad-spectrum antiviral agent remdesivir is a nucleotide analog prodrug. On May 1, 2020, The FDA has granted an emergency use authorization (EUA) for remdesivir to treat hospitalized adults and children with suspected or laboratory-confirmed SARS CoV-2 infection and severe COVID-19 disease.
MANDATORY REQUIREMENTS FOR R...
Physicians are at high-risk of contracting coronavirus disease (COVID-19) due to close contact with infected patients, consequently, they might act as potential spreader of infections among non-infected patients.
Hence, many physicians suspended clinical practice in their private chambers since Corona outbreak. Considering current needs of he...
The COVID-19 pandemic brought telemedicine into a new light. As medical professionals need to stay healthy and disease-free, they need for remote technologies. Both the CDC and WHO are advocating for telemedicine to monitor patients and reduce risks of them spreading the virus by traveling to hospitals and doctor’s chamber.
The COVID...
A 33-year-old man in Hong Kong may represent the first confirmed case of reinfection, researchers in Hong Kong said. He was reinfected with the novel coronavirus, but didn't develop any symptoms the second time. Viral sequence disparity indicates Hong Kong case not simply prolonged infection.
The man was diagnosed with COVID-19 on Marc...
What is herd immunity?
When most of a population is immune to an infectious
disease, this provides indirect protection—or herd immunity (also called herd
protection)—to those who are not immune to the disease.Sponsored content
